Muscular dystrophy-white matter spongiosis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1877
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Muscular dystrophy-white matter spongiosis syndrome is an extremely rare genetic condition that combines two major problems: progressive muscle weakness (muscular dystrophy) and abnormal changes in the brain's white matter called spongiosis. White matter is the part of the brain that connects different brain regions and helps send signals throughout the nervous system. When spongiosis occurs, tiny fluid-filled spaces form in this white matter, which can interfere with normal brain function. Patients with this syndrome typically experience progressive muscle weakness and wasting, which can affect the ability to walk and perform daily activities. Brain involvement may lead to developmental delays, intellectual disability, or neurological decline over time. The combination of muscular and brain problems makes this condition particularly challenging for affected individuals and their families. Because this syndrome is so rare, there are very few reported cases in the medical literature. There is currently no cure or disease-specific treatment available. Management focuses on supportive care, including physical therapy to maintain muscle function, neurological monitoring, and addressing symptoms as they arise. Research into the underlying genetic cause and potential treatments is still in very early stages.

Key symptoms:

Progressive muscle weaknessMuscle wastingDifficulty walking or inability to walkDevelopmental delayIntellectual disabilityAbnormal brain white matter on MRILow muscle tone (floppiness)Difficulty with motor skillsPossible seizuresFeeding difficulties in infancyLoss of previously acquired skills

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Muscular dystrophy-white matter spongiosis syndrome.

View clinical trials →

No actively recruiting trials found for Muscular dystrophy-white matter spongiosis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Muscular dystrophy-white matter spongiosis syndrome community →

No specialists are currently listed for Muscular dystrophy-white matter spongiosis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Muscular dystrophy-white matter spongiosis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Muscular dystrophy-white matter spongiosis syndromeForum →

No community posts yet. Be the first to share your experience with Muscular dystrophy-white matter spongiosis syndrome.

Start the conversation →

Latest news about Muscular dystrophy-white matter spongiosis syndrome

2 articles
AdvocacyRSSApr 22, 2026
To me, a wheelchair is a symbol of improved function, not disability
A person with a muscular dystrophy explains how using a wheelchair has improved their quality of life and ability to participate in daily activities. Rather tha
AdvocacyRSSApr 22, 2026
Navigating disability benefits for muscular dystrophy
When muscular dystrophy makes it hard to work, you may qualify for disability benefits that provide money and health insurance. This article explains how to nav
See all news about Muscular dystrophy-white matter spongiosis syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific tests have been done to confirm this diagnosis, and are there additional tests we should consider?,Is genetic testing available that might identify the exact cause of this condition?,What therapies are recommended to help maintain my child's muscle strength and function?,How should we monitor for breathing or swallowing problems?,Are there any clinical trials or research studies we could participate in?,What specialists should be part of our care team?,What is the expected course of this condition, and how can we best prepare?

Common questions about Muscular dystrophy-white matter spongiosis syndrome

What is Muscular dystrophy-white matter spongiosis syndrome?

Muscular dystrophy-white matter spongiosis syndrome is an extremely rare genetic condition that combines two major problems: progressive muscle weakness (muscular dystrophy) and abnormal changes in the brain's white matter called spongiosis. White matter is the part of the brain that connects different brain regions and helps send signals throughout the nervous system. When spongiosis occurs, tiny fluid-filled spaces form in this white matter, which can interfere with normal brain function. Patients with this syndrome typically experience progressive muscle weakness and wasting, which can aff

How is Muscular dystrophy-white matter spongiosis syndrome inherited?

Muscular dystrophy-white matter spongiosis syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Muscular dystrophy-white matter spongiosis syndrome typically begin?

Typical onset of Muscular dystrophy-white matter spongiosis syndrome is infantile. Age of onset can vary across affected individuals.